Scientists in Uruguay have found genotypes of the human papillomavirus (HPV) linked to cervical cancer in urban wastewater, ...

HPV (human papillomavirus) is a common virus in the UK, and it is estimated that eight out of 10 people will be infected with HPV at some point in their lives. Chris Johnson, Head of the Vaccine ...

HPV is one of the most common infections causing genital warts or cervical cancer in women. Vaccination is the best way to prevent the disease. The vaccine has already been introduced in 140 countries ...

One of the most effective ways to protect against cervical cancer is through the Human Papillomavirus (HPV) vaccine. While the vaccine is widely recognized for its role in preventing cervical cancer, ...

In fact, it protects reproductive health by preventing HPV-related cancers. Myth 2: The HPV vaccine encourages promiscuity Some critics argue that vaccinating girls against a sexually transmitted ...

A team led by scientists at the University of Nottingham's School of Pharmacy demonstrated a new cryogenic mass spectrometry approach for depth profiling frozen tiny lipid nanoparticles to reveal the ...

Despite the world possessing effective vaccines against HPV, rates of immunisation are actually falling in lower- and middle-income countries. Ben Hargreaves asks why this is happening ...

Dr Sonia Golani provides essential insights into everything you need to know about HPV vaccines for cervical cancer prevention. Cervical cancer is one of the most preventable types of cancer, yet it ...

The advent of the HPV vaccine may potentially be a game-changer for the prevention of HPV-linked cancer through oral sex. The new generation of women protected by such vaccination is likely to ...

The HPV vaccine programme was introduced in Scotland in September 2008 – but uptake rates have dropped globally since the Covid pandemic. Now, researchers at Edinburgh Napier University are ...

Robert Langer, chemical ... in structure, were discovered while the firms were optimizing LNPs for systemic administration and delivery to the liver—not the intramuscular injection of a vaccine.

One of the main challenges of developing an HIV-1 vaccine lies in eliciting immune ... we highlight the relationship between 3D molecular structure, biological function and immunological cross ...